OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
A Trial of Centanafadine Efficacy and Safety in Adults With Attention-deficit/Hyperactivity Disorder and Comorbid Anxiety
- Conditions
- ADHDAnxietyGeneralized AnxietySocial Anxiety Disorder
- Interventions
- Other: Placebo
- First Posted Date
- 2025-05-15
- Last Posted Date
- 2025-05-31
- Target Recruit Count
- 308
- Registration Number
- NCT06973577
- Locations
- 🇺🇸
Clinical Research Site #017 - Harmonex Neuroscience Research, Dothan, Alabama, United States
🇺🇸Clinical Research Site #011 - NRC Research Institute, Orange, California, United States
🇺🇸Clinical Research Site #005 - Clinical Neuroscience Solutions, Inc., Jacksonville, Florida, United States
A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)
- Conditions
- Phenylketonuria
- Interventions
- Drug: JNT-517 Tablet
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-06-03
- Target Recruit Count
- 120
- Registration Number
- NCT06971731
A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's
- Conditions
- Sjogren Disease
- Interventions
- Other: Placebo
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-04-15
- Target Recruit Count
- 80
- Registration Number
- NCT06928142
- Locations
- 🇺🇸
Medvin Clinical Research - Riverside, Riverside, California, United States
🇺🇸Medvin Clinical Research - Tujunga, Tujunga, California, United States
🇺🇸Bay Area Arthritis and Osteoporosis, Brandon, Florida, United States
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-05-18
- Target Recruit Count
- 522
- Registration Number
- NCT06894212
- Locations
- 🇺🇸
Pillar Clinical Research LLC - Bentonville Site # 145, Bentonville, Arkansas, United States
🇺🇸Pillar Clinical Research (Little Rock AR) Site #153, Little Rock, Arkansas, United States
🇺🇸Woodland International Research Group Site #141, Little Rock, Arkansas, United States
A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-27
- Target Recruit Count
- 264
- Registration Number
- NCT06795399
A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)
- Conditions
- Systemic Lupus Erythematosus (SLE)Alopecia Areata (AA)Immune-mediated Focal Segmental Glomerulosclerosis (FSGS)
- Interventions
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-04-11
- Target Recruit Count
- 30
- Registration Number
- NCT06799520
- Locations
- 🇲🇩
Visterra Investigational Site, Chisinau, Moldova, Republic of
Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2025-04-06
- Target Recruit Count
- 25
- Registration Number
- NCT06740526
- Locations
- 🇺🇸
Clinical Research Site 330, Denver, Colorado, United States
🇺🇸Clinical Research Site 369, Boston, Massachusetts, United States
🇺🇸Clinical Research Site 374, Dakota Dunes, South Dakota, United States
A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria
- Conditions
- Phenylketonuria (PKU)
- Interventions
- Drug: JNT-517 TabletOther: Placebo
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2025-06-03
- Target Recruit Count
- 10
- Registration Number
- NCT06637514
A Study to Evaluate the Long-Term Safety and Efficacy of JNT-517 in Participants With Phenylketonuria
- Conditions
- Phenylketonuria (PKU)
- Interventions
- Drug: JNT-517 Tablet
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2025-06-03
- Target Recruit Count
- 45
- Registration Number
- NCT06628128
A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion
- Conditions
- Mental DisorderSchizophreniaMajor Depressive DisorderBipolar I Disorder
- Interventions
- First Posted Date
- 2024-04-17
- Last Posted Date
- 2024-07-31
- Target Recruit Count
- 54
- Registration Number
- NCT06372210
- Locations
- 🇺🇸
Research site, Garden Grove, California, United States